Feedback Share Discussion Threads

[hazl] 08/9/2019 17:28

Absolutely!

The potential of other uses is restricted only by the imagination.

[ged5] 08/9/2019 17:21

Yes, thank you,I remember you posting that, Hazl. It's not going to be just yet but certainly further potential. How much more do think it might generate. Piece of string come to mind?

Thanks George! Other party, anyone from FDBK? Did you mention this before. I seem to remember some comment on this topic. I'm sure Future Processing could handle that. It will be needed for international use though I would have thought.

Thanks Bob! Best to be cautious. I'm useless at forecasting the share price As I said before, there are so many variables. But hey 2.5p is a triple bag for some of our purchases.

[bobd29] 08/9/2019 16:44

HiGED5 I asked out of interest and your figs are as good as any. Yes the first NHS contracts are crucial, after that international deals are the cream.my use of a 10x PER is conservative on purpose it could easily be 20x or more depending on success. Again being cautious I will be content with 2.5p end this year.that would clear any overhang. Next year all up for grabs, glad, dyor.

[bobd29] 08/9/2019 16:44

HiGED5 I asked out of interest and your figs are as good as any. Yes the first NHS contracts are crucial, after that international deals are the cream.my use of a 10x PER is conservative on purpose it could easily be 20x or more depending on success. Again being cautious I will be content with 2.5p end this year.that would clear any overhang. Next year all up for grabs, glad, dyor.

[georgesorearse] 08/9/2019 16:30

GED... I was discussing this and the other party had a cracking idea for bleepa stage 2. translation app with flags at the bottom ... stage 1 English speaking countries ... stage 2 translation app although needs to be spot on 100% system so needs advances from current systems.

[hazl] 08/9/2019 16:11

'Absolutely! #Bleepa is aimed initially at healthcare applications but there are many potential industries that would benefit from secure, high res messaging...watch this space
😉

[hazl] 08/9/2019 16:02

...it's understandable that everybody is concentrating on the medical-field for Bleepa's
uses,as indeed Feedback do currently.

But don't dismiss other areas, which are in my opinion,countless.
When I put this to the company they commented in the affirmative, as if they had been already thinking of various,differing avenues saying 'Watch this space'!

[ged5] 08/9/2019 16:01

An old link given by LR2 but shows why I mentioned Imaging Endpoints

"British medical imaging software company, Feedback plc, raised £1.375 million ($1.75M) that it will use to build its sales and marketing team, expand its Cadran PACS customer base/customer support, fund the FDA clearance process for its TexRAD texture analysis software, and develop its US sales partnership with Imaging Endpoints. Although not mentioned in the announcement, GE Healthcare gained global rights to distribute TexRAD in April, suggesting that the software’s US expansion may be supported by a formidable partner."

[ged5] 08/9/2019 15:46

I did ask for views, Onjohn so thank you for your views. What have you based your insightful comment on please?

[ged5] 08/9/2019 15:44

Not really sure that's how a PER works but yes there have been several calculations earlier on this thread about the potential market. LR2, Bob and myself have all offered calculations. Theirs better than mine.

With 15M doctors worldwide there is a potential market of 1.8Billion. Even with just 3% (Plucked out of the air) of that market that's 54M or 8 times the present Mkt Cap.

But yes India has been mentioned a lot on this thread. So if the market sees the potential of future orders then why not?

There's also China and South Korea. And what role might Imaging Endpoints have in the US. LR2 knows more about them.

We need NHS over the next few weeks/months but then I agree India could be the real company maker.

[georgesorearse] 08/9/2019 15:16

Imagine if some Indian billionaire identifies the potential and health saving and wants to cornerstone this ....

[georgesorearse] 08/9/2019 15:15

GED.. I think the real clincher here is India.. NHS will be great for profitability but for a p.e over 20 look at their population count ... and growing. ... is a p.e of 50 possible ??

[georgesorearse] 08/9/2019 15:13

GED.. I think the real clincher here is India.. NHS will be great for profitability but for a p.e over 20 look at their population count ... and growing. ... is a p.e of 50 possible ??

[ged5] 08/9/2019 13:18

I notice Herald had £160000 of shares in the previous placing which equates to about 2.8%

If they have taken place in the recent placing and want to keep under 3% they would only be able to buy 5.5M shares.

[ged5] 08/9/2019 12:43

Good afternoon Bob,

The most likely hospital to take up Bleepa is The Royal Papworth, where Cadran is already in use. There are about 1700 staff. I don't know how many clinicians are there (If anyone knows please let me know) so I've used about a third of the staff.

If they pay the full amount (I would imagine they will get a good discount because they are paying £120000 for Cadran) So using the full amount we have £60000 per year. On that basis we would need about 83 similar hospitals to take up Bleepa. I've not factored in the possibility of them purchasing Cadran as well.

With the 563K there would be revenue of about £55.4M per annum. With outgoings of approximately £1.2M that's about net earnings 43.4M.

Using a PE of 10 that gives a Mkt Cap of 43M or a share price of 8p.

Of course if Bleepa is seen as a success (we'll find out over the next few months) the PE will be more like x20 or even more. In which case orders from only 47 hospitals or less.

There are so many variables here. If 30 hospitals also take up Cadran that's another 3.6M.

Then there's phase 2 of the review. How much extra will TO's innovative idea for TexRAD bring in? Thanks to LR2 we might have some idea of the area where TexRAD will be used.

How much will Stonechecker contribute?

Any more orders for TexRad

So the answer to your question is soon after we hear about orders for Bleepa.

I would like to hear views from others.

Edit I've changed some of the figures. I'd used £563 instead of 563000 for the present income!

[bobd29] 07/9/2019 09:56

Morning lr2, haven’t seen that before so assume research version. Interesting post Brexit do further TexRAD incarnations require CE Mark? TexRAD still my main interest so awaiting TO update. Incidentally GED when is your 8p target price anticipated?
Hoping for news update in the next few weeks.

[lr2] 06/9/2019 23:59

BTW - new report - TexRAD being tested on brain tumours. Have sent you the info.

[ged5] 06/9/2019 23:50

He makes some good points but I sense an agenda. Thanks for the support.

[lr2] 06/9/2019 23:47

Yes, I thought it was probably a load of old rollox too, Ged.

[ged5] 06/9/2019 23:45

George, reading post 2821, I think we are on the same wavelength. We're all traders, just different timespans.

Accuse me of being autistic (my offspring do!) but there were six people on the stand.

If you look back through the thread you'll see several calculations which give us cause for optimism. Provided there is no more dilution and Bleepa is well received I think 8p is a reasonable target price.

[ged5] 06/9/2019 23:35

I was replying to 2812, George.

[ged5] 06/9/2019 23:32

Well George you seem to have the support of 5 readers so who am I to argue. Oh I started this thread when I became a shareholder Oct/Nov 2018.

Now on the face of it your post looks superb. So let's examine it a little more carefully.

First of all you address it to the most manipulative poster who has almost single handedly destroyed this thread.

Then you give us your methods of research. Wow you read all the blurb! Well who would have thought that anyone would do that?

Then you make a complete pest of yourself. Hmmm

You contacted the CEO? Who else might have done that? A few on here maybe?

Is TexRAD really being prepared? For Bleepa maybe but certainly a review. Oh yes we can all read announcements. Who would have thought? But how many articles have there been on TexRAD?

Now this is the part that ruined your post and why I'm even bothering to reply to you. It shows you have an agenda here:-

"really liked the idea of it so much it overrode everything else which as it comes from you lot is completely negative - and I can't blame any of you for that, your lack of support for the product is letting me buy cheaply so thank you."

Well that just proves you haven't read anything on this thread.

You spoke to ex-medical people? Wow, fantastic! Who else would have thought to do that? Well not me. I've spoken to present medical people.

Most of the rest of the post is quite good but don't assume all doctors have the latest phones.

Was the lowest buy 1.215 or was it 1.999?

[georgesorearse] 06/9/2019 23:28

Hazl - from the graphs older holders been from 0.75 and up to 3p, I'd have been trading it as well, looking at it now for entry at 1.2/1.3 is okay to just buy and hold for 6 months - if it comes off great - if it doesn't swallow the loss and move on - really lazy investing but very acceptable risk I think.

The NHS Expo gave them access to 6000 people, lets say they had 5 people on their stand who saw 5 people an hour, 12 minutes per contact, for 7 hours a day for 2 days ... 350 sales targets... out of 6000 delegates so a 5.83% hit rate or double if it was the same attendees over two days and no one revisited the stand - as per someones post on linked she walked past and TO was busy each time.

The bit I really liked was he chased her up for an appointment .... has a product - wants to sell it.

Those 350 people or 700, half will forget what they have seen as sensory overload at those events is high, so 175 or 350 people will remember to google #BLEEPA to review it or those half (87 people or 174 ) will then take their interest further and research it and talk to their colleagues, superiors .....

These are the harsh realities of an Expo event - high cost, slow burn return ....

Now we wait for the 174 to talk - everybody talks, they exchange, explore and then like the AIM mythical herd arriving, people in an enclosed space reach a common consensus individually at the same moment .... contracts and share price increase ......

We were over subscribed from the recent placing - that was awful and everyone hates it, the share price crashed and it was naive, bloke fell on his sword and left the BOD - however now we have done the EXPO we have time on our side, because we have funds in the bank we can negotiate on contracts from a position of relative strength not desperation to give our product away, give the punters time to talk it through study their own requirements and realise that the ex head of NHS Technology integration has done their thinking and cash flow expenditure for them....

Time To Buy Is Now

Game On.